These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12031392)

  • 1. Evaluation of intraprostatic metabolism of 1,25-dihydroxyvitamin D(3) (calcitriol) using a microdialysis technique.
    Konety BR; Somogyi G; Atan A; Muindi J; Chancellor MB; Getzenberg RH
    Urology; 2002 Jun; 59(6):947-52. PubMed ID: 12031392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.
    Muindi JR; Modzelewski RA; Peng Y; Trump DL; Johnson CS
    Oncology; 2004; 66(1):62-6. PubMed ID: 15031600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patients.
    Muindi JR; Wilson JW; Peng Y; Capozolli MJ; Johnson CS; Trump DL
    J Clin Pharmacol; 2003 Aug; 43(8):894-900. PubMed ID: 12953346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.
    Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O
    Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and prepubertal prostate.
    Konety BR; Leman E; Vietmeier B; Arlotti J; Dhir R; Getzenberg RH
    J Urol; 2000 Nov; 164(5):1812-8. PubMed ID: 11025775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel.
    Muindi JR; Peng Y; Potter DM; Hershberger PA; Tauch JS; Capozzoli MJ; Egorin MJ; Johnson CS; Trump DL
    Clin Pharmacol Ther; 2002 Dec; 72(6):648-59. PubMed ID: 12496746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and androgen regulation of prostatic growth.
    Leman ES; Arlotti JA; Dhir R; Getzenberg RH
    J Cell Biochem; 2003 Sep; 90(1):138-47. PubMed ID: 12938163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
    Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
    Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.
    Beer TM; Lemmon D; Lowe BA; Henner WD
    Cancer; 2003 Mar; 97(5):1217-24. PubMed ID: 12599228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
    Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
    Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 22-oxacalcitriol on serum calcitriol.
    Dusso AS; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
    Endocrinology; 1992 Jun; 130(6):3129-34. PubMed ID: 1597134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duodenal active calcium transport in female rats increases with serum calcitriol concentrations, but reaches a plateau far below maximal calcitriol levels.
    Boass A; Toverud SU
    J Bone Miner Res; 1996 Nov; 11(11):1640-5. PubMed ID: 8915771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
    Torregrosa JV; Fuster D; Ybarra J; Ortín J; Moreno A; Valveny N
    Am J Kidney Dis; 2004 Sep; 44(3):476-80. PubMed ID: 15332220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion properties of transurethral intraprostatic injection.
    Plante MK; Gross AL; Folsom JB; Zvara P
    BJU Int; 2004 Dec; 94(9):1384-8. PubMed ID: 15610125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.
    Muindi JR; Potter DM; Peng Y; Johnson CS; Trump DL
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):492-6. PubMed ID: 15918041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
    Knutson JC; LeVan LW; Valliere CR; Bishop CW
    Biochem Pharmacol; 1997 Mar; 53(6):829-37. PubMed ID: 9113104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.